Recombinant TNFSF13B (Belimumab Biosimilar) antibody
The Human Monoclonal anti-TNFSF13B (Belimumab Biosimilar) antibody is suitable to detect TNFSF13B (Belimumab Biosimilar) in samples from Human. It has been validated for ELISA, FACS, BLI, Func and SPR.
Catalog No. ABIN7675701
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant TNFSF13B (Belimumab Biosimilar) antibody (ABIN7675701)
Target
TNFSF13B (Belimumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This TNFSF13B (Belimumab Biosimilar) antibody is un-conjugated
Application
ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-TNFSF13B / BAFF / CD257 Reference Antibody (belimumab)
-
Characteristics
- Anti-TNFSF13B / BAFF / CD257 Reference Antibody (belimumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hulambda. It has a predicted MW of 144.56 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- TNFSF13B (Belimumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 144.56 kDa
-
UniProt
- Q9Y275
Target
-
You are here:
